Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East.
Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months.
Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months.
Framework contract: £665,389,588 total value shared among 25 suppliers. Estimated equal shares shown below.
| Supplier | Identifier | Est. Share | Lots Won | Cross-References |
|---|---|---|---|---|
| ACCORD-UK LTD | Procurement ID: PBTN-3137-DHTG | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| AMGEN LIMITED | Procurement ID: PDJG-8184-TCQQ | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| AVENTIS PHARMA LIMITED t-a Sanofi | Procurement ID: PMBG-8218-QDPT | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| BAYER PLC | 00935048 | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | LOBBYIST Ovid Consulting Ltd (6 quarters) Hill & Knowlton Limited (2 quarters) iNHouse Communications Limited (1 quarter) Hanover Communications International Limited (1 quarter) |
| BIOGEN IDEC LIMITED | Procurement ID: PTGT-3385-PBMQ | ~£26,615,584 | 2 lots CM/PHR/25/5730/01 - Tranche B for NOFE and MAE · CM/PHR/25/5730/02 - Natalizumab for London & SOFE | - |
| CHUGAI PHARMA LIMITED | Procurement ID: PMQZ-8161-PLDQ | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| CIPLA (EU) LIMITED | Procurement ID: PRLC-3564-DJDN | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| CST PHARMA LIMITED | Procurement ID: PBDW-5911-ZDBQ | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| ELI LILLY & COMPANY LTD | Procurement ID: PTTR-3628-HTTN | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| GEDEON RICHTER (UK) LIMITED | Procurement ID: PVNN-9371-ZTBW | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| GLAXOSMITHKLINE UK LIMITED | Procurement ID: PNVC-2547-YXMP | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| LABORATORIES JUVISE PHARMACEUTICALS | Procurement ID: PMCH-3827-GJZN | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| MERCK SERONO LIMITED | Procurement ID: PYQR-6988-GHRW | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| MILPHARM LIMITED | Procurement ID: PCYZ-5538-QLGR | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| NAPP PHARMACEUTICALS LTD | Procurement ID: PJJB-3288-JNGG | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| NOVO NORDISK | 01118740 | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | LOBBYIST WA Communications Ltd (7 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
| ORIFARM UK LTD | Procurement ID: PQPW-1715-PJLT | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| PFIZER LIMITED | Procurement ID: PCQW-3224-CMTG | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| PHARMACOSMOS UK LTD | Procurement ID: PVYL-1477-WWCH | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| ROCHE PRODUCTS LIMITED | Procurement ID: PXCG-4172-CHYM | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| SANDOZ LIMITED | Procurement ID: PNQL-1548-CYBZ | ~£26,615,584 | 2 lots CM/PHR/25/5730/01 - Tranche B for NOFE and MAE · CM/PHR/25/5730/02 - Natalizumab for London & SOFE | - |
| TEVA UK LIMITED | Procurement ID: PWDD-6894-DXRM | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| THORNTON & ROSS LIMITED | Procurement ID: PWYH-6892-QYNN | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| VIATRIS UK HEALTHCARE LTD | Procurement ID: PQLZ-4934-WXRZ | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
| VIFOR PHARMA UK LTD | Procurement ID: PTLY-2878-GQMZ | ~£26,615,584 | 1 lot CM/PHR/25/5730/01 - Tranche B for NOFE and MAE | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 2 lots, each awarded separately. 27 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 CM/PHR/25/5730/01 - Tranche B for NOFE and MAE Sept 2026 – Aug 2028 | £846,138,512 £665,389,588 initial term | 25 | AVENTIS PHARMA LIMITED t-a Sanofi ACCORD-UK LTD AMGEN LIMITED BIOGEN IDEC LIMITED CHUGAI PHARMA LIMITED CIPLA (EU) LIMITED CST PHARMA LIMITED ELI LILLY & COMPANY LTD GEDEON RICHTER (UK) LIMITED GLAXOSMITHKLINE UK LIMITED LABORATORIES JUVISE PHARMACEUTICALS MERCK SERONO LIMITED MILPHARM LIMITED NAPP PHARMACEUTICALS LTD ORIFARM UK LTD PFIZER LIMITED PHARMACOSMOS UK LTD ROCHE PRODUCTS LIMITED SANDOZ LIMITED TEVA UK LIMITED THORNTON & ROSS LIMITED VIATRIS UK HEALTHCARE LTD VIFOR PHARMA UK LTD | active |
| Lot 2 CM/PHR/25/5730/02 - Natalizumab for London & SOFE Sept 2026 – Aug 2027 | £31,532,058 £35,312,548 initial term | 2 | BIOGEN IDEC LIMITED SANDOZ LIMITED | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| BIOGEN IDEC LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| SANDOZ LIMITED | Lots 1, 2 | Wonlots 1, 2 |
| ACCORD-UK LTD | Lot 1 | Wonlot 1 |
| AMGEN LIMITED | Lot 1 | Wonlot 1 |
| AVENTIS PHARMA LIMITED t-a Sanofi | Lot 1 | Wonlot 1 |
| BAYER PLC | Lot 1 | Wonlot 1 |
| CHUGAI PHARMA LIMITED | Lot 1 | Wonlot 1 |
| CIPLA (EU) LIMITED | Lot 1 | Wonlot 1 |
| CST PHARMA LIMITED | Lot 1 | Wonlot 1 |
| ELI LILLY & COMPANY LTD | Lot 1 | Wonlot 1 |
| GEDEON RICHTER (UK) LIMITED | Lot 1 | Wonlot 1 |
| GLAXOSMITHKLINE UK LIMITED | Lot 1 | Wonlot 1 |
| LABORATORIES JUVISE PHARMACEUTICALS | Lot 1 | Wonlot 1 |
| MERCK SERONO LIMITED | Lot 1 | Wonlot 1 |
| MILPHARM LIMITED | Lot 1 | Wonlot 1 |
| NAPP PHARMACEUTICALS LTD | Lot 1 | Wonlot 1 |
| NOVO NORDISK | Lot 1 | Wonlot 1 |
| ORIFARM UK LTD | Lot 1 | Wonlot 1 |
| PFIZER LIMITED | Lot 1 | Wonlot 1 |
| PHARMACOSMOS UK LTD | Lot 1 | Wonlot 1 |
| ROCHE PRODUCTS LIMITED | Lot 1 | Wonlot 1 |
| TEVA UK LIMITED | Lot 1 | Wonlot 1 |
| THORNTON & ROSS LIMITED | Lot 1 | Wonlot 1 |
| VIATRIS UK HEALTHCARE LTD | Lot 1 | Wonlot 1 |
| VIFOR PHARMA UK LTD | Lot 1 | Wonlot 1 |
Weightings from the notice, applied to every lot.
Government spending data: These suppliers have received £120,488,779 in 2,465 payments (over £25k) from Manchester University NHS Foundation Trust, East Sussex Healthcare NHS Trust, Worcestershire Acute Hospitals NHS Trust, Guy's and St Thomas' NHS FT, Royal Cornwall Hospitals NHS Trust and 13 more public bodies (2018-04-04 to 2026-03-26).
Changes the buyer published to this notice after it first appeared.
Updated to Above Threshold Tender
Date for Tender Registration Updated